Amnioderm

Amnioderm is a biological wound dressing composed of lyophilized, non-viable human amniotic membrane (HAM). Developed by Bio-Healing, it is processed to retain the natural extracellular matrix (ECM) structure and endogenous bioactive components, including growth factors (such as EGF, TGF-β, and FGF) and cytokines, which facilitate re-epithelialization and reduce inflammation. Amnioderm is primarily utilized for the treatment of chronic, non-healing wounds, particularly diabetic foot ulcers (DFUs), where it has demonstrated significant efficacy in accelerating wound closure compared to standard of care. It is also applied in specialized cases such as reconstructive surgery for epidermolysis bullosa and the management of toxic epidermal necrolysis (TEN) to provide mechanical protection and pain relief. The product is regulated as a medical device in certain jurisdictions and is available in a freeze-dried form that allows for room-temperature storage and ease of application.

Brand names

AmniodermAMNIODERM+

Other names

lyophilized human amniotic membranefreeze-dried human amniotic membrane allograftnon-viable human amniotic membraneHAM